Approval for a manufacturing site located at orifice medical ab in ystad, sweden.
Device | PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES |
Classification Name | System, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy |
Generic Name | System, Hyperthermia, Rf/microwave (benign Prostatic Hyperplasia),thermotherapy |
Applicant | PROSTALUND AB |
Date Received | 2014-02-21 |
Decision Date | 2014-07-30 |
PMA | P010055 |
Supplement | S009 |
Product Code | MEQ |
Advisory Committee | Gastroenterology/Urology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Location Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | PROSTALUND AB scheelevagen 17 se-223 63 Lund SE-22-223 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P010055 | | Original Filing |
S011 |
2021-06-03 |
30-day Notice |
S010 | | |
S009 |
2014-02-21 |
Normal 180 Day Track No User Fee |
S008 | | |
S007 |
2009-09-09 |
Normal 180 Day Track |
S006 |
2009-04-02 |
Normal 180 Day Track No User Fee |
S005 |
2009-04-02 |
Normal 180 Day Track No User Fee |
S004 |
2007-05-25 |
30-day Notice |
S003 |
2006-11-22 |
30-day Notice |
S002 |
2004-09-30 |
Normal 180 Day Track No User Fee |
S001 |
2004-07-30 |
Normal 180 Day Track |
NIH GUDID Devices